Development and acceptability of a patient decision aid for people with degenerative cervical myelopathy: an international mixed-methods study

OBJECTIVES: To develop and user-test a patient decision aid for people diagnosed with degenerative cervical myelopathy and who are considering surgery. DESIGN: Mixed-methods study describing the development of a patient decision aid. SETTING: A draft decision aid was developed by a multidisciplinary steering group (including study authors with degenerative cervical myelopathy, health professionals and researchers) informed by the best available evidence, authorship consensus and existing patient decision aids. PARTICIPANTS: Patient-participants and health professional-participants who manage people with degenerative cervical myelopathy were recruited through social media and the steering group's research and practice network. Quantitative questionnaires were used to gather baseline data, descriptive feedback, refine the decision aid and assess its acceptability. Qualitative semi-structured interviews were conducted online to gather feedback on the decision aid and were analysed using reflexive thematic analysis. RESULTS: We conducted 32 interviews: 19 patient-participants and 13 health professional-participants who manage people with degenerative cervical myelopathy (neurosurgeons, neurologists, physiotherapists, orthopaedic surgeons, general practitioners, rehabilitation and pain specialists and consultant occupational physicians and chiropractors). Participants were from 10 countries (Australia, Canada, Cyprus, Germany, Ireland, New Zealand, Sweden, Switzerland, United Kingdom and USA). Most participants rated the decision aid's acceptability as good-to-excellent and agreed with most aspects of the decision aid (eg, defining degenerative cervical myelopathy, management recommendations, potential benefits and harms, questions to consider asking a health professional). CONCLUSION: Our patient decision aid was rated as an acceptable tool by both health professional-participants who treat degenerative cervical myelopathy and patient-participants with lived experience of degenerative cervical myelopathy. This decision aid can be used by clinicians and people with degenerative cervical myelopathy to help with shared decision making following a diagnosis of degenerative cervical myelopathy. A study testing the potential benefits of this decision aid in a clinical setting is recommended.

Authors

Institutions

Publication Details

Journal
BMJ Open
Published
2026-04-01
DOI
https://doi.org/10.1136/bmjopen-2025-106337
Primary Topic
Patient-Provider Communication in Healthcare
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development and acceptability of a patient decision aid for people with degenerative cervical myelopathy: an international mixed-methods study

Samuel Xavier Stevens, Benjamin M. Davies, Joshua R Zadro, Carlo Ammendolia et al.
BMJ Open
Patient-Provider Communication in Healthcare
article

Development and acceptability of a patient decision aid for people with degenerative cervical myelopathy: an international mixed-methods study

Samuel Xavier Stevens, Benjamin M. Davies, Joshua R Zadro, Carlo Ammendolia, Rohil Chauhan, Carl Moritz Zipser, Marnee J. McKay, Timothy F. Boerger, Justin M. Lantz, Rana Dhillon, Andrew R Gamble, Tammy Hoffmann, Chris G. Maher, C. R. Nugent, James M. van Gelder, Sophie Macpherson, Kirsten McCaffery, Michael G Fehlings, Lindsay A Tetreault, Andreas K Demetriades, Helen Holmgren, Elanor Dustan, David B Anderson
article en

Abstract

OBJECTIVES: To develop and user-test a patient decision aid for people diagnosed with degenerative cervical myelopathy and who are considering surgery. DESIGN: Mixed-methods study describing the development of a patient decision aid. SETTING: A draft decision aid was developed by a multidisciplinary steering group (including study authors with degenerative cervical myelopathy, health professionals and researchers) informed by the best available evidence, authorship consensus and existing patient decision aids. PARTICIPANTS: Patient-participants and health professional-participants who manage people with degenerative cervical myelopathy were recruited through social media and the steering group's research and practice network. Quantitative questionnaires were used to gather baseline data, descriptive feedback, refine the decision aid and assess its acceptability. Qualitative semi-structured interviews were conducted online to gather feedback on the decision aid and were analysed using reflexive thematic analysis. RESULTS: We conducted 32 interviews: 19 patient-participants and 13 health professional-participants who manage people with degenerative cervical myelopathy (neurosurgeons, neurologists, physiotherapists, orthopaedic surgeons, general practitioners, rehabilitation and pain specialists and consultant occupational physicians and chiropractors). Participants were from 10 countries (Australia, Canada, Cyprus, Germany, Ireland, New Zealand, Sweden, Switzerland, United Kingdom and USA). Most participants rated the decision aid's acceptability as good-to-excellent and agreed with most aspects of the decision aid (eg, defining degenerative cervical myelopathy, management recommendations, potential benefits and harms, questions to consider asking a health professional). CONCLUSION: Our patient decision aid was rated as an acceptable tool by both health professional-participants who treat degenerative cervical myelopathy and patient-participants with lived experience of degenerative cervical myelopathy. This decision aid can be used by clinicians and people with degenerative cervical myelopathy to help with shared decision making following a diagnosis of degenerative cervical myelopathy. A study testing the potential benefits of this decision aid in a clinical setting is recommended.

BMJ OpenVol. 16(4)
Marquette University (US), University of Southern California (US), Bond University (AU), The University of Sydney (AU), University Health Network (CA), Nottingham University Hospitals NHS Trust (GB), The University of Melbourne (AU), University of Toronto (CA), Queen's University (CA), University of Cambridge (GB), Concord Repatriation General Hospital (AU), Edinburgh Royal Infirmary (GB), UNSW Sydney (AU), Auckland University of Technology (NZ), St Vincent's Hospital Melbourne (AU), Bridge University (SS), University Hospital of Zurich (CH), Institute for Musculoskeletal Health (AU), Universitätsklinik Balgrist (CH), Mass General Brigham (US)
Medical Research Council, National Health and Medical Research Council
Peace, Justice and strong institutions
Openalex Percentile: Top 30%
Patient-Provider Communication in Healthcare
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.